Vital Care Express

stethoscopePulmonology

The latest pulmonology news and research from Vital Care Express, with the questions patients and clinicians actually ask.

Phase 2 Mosliciguat Trial Yields 56.3 Percent PVR Reduction in PH-ILD, Phase 3 PHrontier Begins

Mosliciguat Shows 56.3 Percent PVR Cut in Phase 2 PH-ILD Study